The latest oncology survivorship news & quality of life updates

Precision medicine improves survival outcomes for patients with metastatic castration-resistant prostate cancer with BRCA gene alterations
Led by Joaquin Mateo, Principal Investigator of the Vall d’Hebron Institute of Oncology’s (VHIO) Prostate Cancer…